Ads
related to: biotech stocksdirexion.com has been visited by 10K+ users in the past month
Search results
Exploring Three Japanese Growth Stocks With Significant Insider Ownership On The Tokyo Stock...
Simply Wall St. via Yahoo Finance· 4 hours agoAmid a backdrop of fluctuating global markets, Japanese equities have shown resilience, supported by...
United Services Automobile Association Raises Stock Position in eBay Inc. (NASDAQ:EBAY)
ETF DAILY NEWS· 15 hours ago(NASDAQ:EBAY – Free Report) by 22.3% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 14,403 shares of the e-commerce company’s stock after ...
Should Abbott and DexCom Investors Be Worried About Vertex Pharmaceuticals?
The Motley Fool via AOL· 14 hours agoIf Vertex disrupts the CGM market, no one can say they couldn't have seen it coming. Should you invest $1,000 in Abbott Laboratories right now? Before you buy stock in Abbott ...
2 Stocks That Could 10x by 2035
Motley Fool via Yahoo Finance· 7 days agoMore positive results could jolt the stock price. If Viking Therapeutics manages to pass every clinical and regulatory obstacle ahead and launches these...
Why Summit Therapeutics Stock Is Sinking Today
Motley Fool via Yahoo Finance· 2 days agoSome aggressive investors could view Summit Therapeutics' pullback as a buying opportunity. However, I think that most investors will be better off...
Reasons to Retain Revvity (RVTY) Stock in Your Portfolio Now
Zacks via Yahoo Finance· 9 hours agoThe immunodiagnostics franchise, which is by far the largest category of the Diagnostics segment,...
No Memes, Ma'am! Try a Sensible Biotech Bet With CytomX Therapeutics Stock.
InvestorPlace· 2 days agoNot long ago, GameStop (NYSE:GME) stock soared and then tanked on the meme-stock waves. A company...
Will IO Biotech (NASDAQ:IOBT) Spend Its Cash Wisely?
Simply Wall St. via Yahoo Finance· 3 days agoBiotech has a market capitalisation of US$84m and burnt through US$72m last year, which is 86% of the company's market value. That suggests the company...
Biotech Catapults 128% On Its Home Run In Lung Disease
Investor's Business Daily· 2 days agoNow, Insmed is planning to ask the Food and Drug Administration to approve its drug, brensocatib, as...
1 Stock That More Than Doubled This Year That I Wouldn't Touch With a 10-Foot Pole | The Motley Fool
The Motley Fool· 6 days agoSmall biotech companies can be explosive. The company's shares are up 229% since January (as of this...
Ad
related to: biotech stocks
